| Literature DB >> 21995976 |
Linda E Kippner1, Nnenna A Finn, Shreya Shukla, Melissa L Kemp.
Abstract
BACKGROUND: Cellular clearance of reactive oxygen species is dependent on a network of tightly coupled redox enzymes; this network rapidly adapts to oxidative conditions such as aging, viral entry, or inflammation. Current widespread use of shRNA as a means to perturb specific redox couples may be misinterpreted if the targeted effects are not monitored in the context of potential global remodeling of the redox enzyme network.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21995976 PMCID: PMC3199260 DOI: 10.1186/1752-0509-5-164
Source DB: PubMed Journal: BMC Syst Biol ISSN: 1752-0509
Figure 1Characterization of shRNA cell lines. (A) β-Actin normalized mRNA levels of target silencing in selected cell lines with respect to pLKO. (B) Expression levels of target protein after stable shRNA silencing of Grx1, Trx1, and G6PD in Jurkat cells compared to pLKO empty vector control. Selected shRNA sequence is denoted with asterisk. (C) Growth curves of selected stable knockdown cell lines show changes in cell proliferation rates between shRNA and control cells. Error bars represent ± standard error (n = 3).
PCR array target list
| Gene Symbol | Alias | Accession # | Official Full Name |
|---|---|---|---|
| CAT | MGC138422/MGC138424 | NM_001752 | Catalase |
| GPX1 | GSHPX1/MGC14399/MGC88245 | NM_000581 | Glutathione peroxidase 1 |
| GSR | MGC78522 | NM_000637 | Glutathione reductase |
| PRDX1 | MSP23/NKEFA/PAG/PAGA/PAGB/PRX1/PRXI/TDPX2 | NM_002574 | Peroxiredoxin 1 |
| PRDX2 | MGC4104/NKEFB/PRP/PRX2/PRXII/TDPX1/TSA | NM_005809 | Peroxiredoxin 2 |
| PRDX4 | AOE37-2/PRX-4 | NM_006406 | Peroxiredoxin 4 |
| APEX1 | APE/APE1/APEN/APEX/APX/HAP1/REF1 | NM_080649 | APEX nuclease (multifunctional DNA repair enzyme) 1 |
| SRXN1 | C20orf139/Npn3/SRX1/YKL086W/dJ850E9.2 | NM_080725 | Sulfiredoxin 1 homolog (S. cerevisiae) |
| TXNRD1 | GRIM-12/MGC9145/TR/TR1/TRXR1/TXNR | NM_003330 | Thioredoxin reductase 1 |
| GLRX | GRX/GRX1/MGC117407 | NM_002064 | Glutaredoxin (thioltransferase) |
| GLRX2 | GRX2/bA101E13.1 | NM_197962 | Glutaredoxin 2 |
| TXN | DKFZp686B1993/MGC61975/TRX/TRX1 | NM_003329 | Thioredoxin |
| TXN2 | MT-TRX/MTRX/TRX2 | NM_012473 | Thioredoxin 2 |
| G6PD | G6PD1 | NM_000402 | Glucose-6-phosphate dehydrogenase |
| IDH1 | IDCD/IDH/IDP/IDPC/PICD | NM_005896 | Isocitrate dehydrogenase 1 (NADP+), soluble |
| IDH2 | ICD-M/IDH/IDHM/IDP/IDPM/mNADP-IDH | NM_002168 | Isocitrate dehydrogenase 2 (NADP+), mitochondrial |
| AQP8 | - | NM_001169 | Aquaporin 8 |
| DUOX1 | LNOX1/MGC138840/MGC138841/NOXEF1/THOX1 | NM_175940 | Dual oxidase 1 |
| DUOX2 | LNOX2/NOXEF2/P138TOX/THOX2 | NM_014080 | Dual oxidase 2 |
| NOX1 | GP91-2/MOX1/NOH-1/NOH1 | NM_007052 | NADPH oxidase 1 |
| CYBB | CGD/GP91-1/GP91PHOX/GP91PHOX/NOX2/p91-PHOX | NM_000397 | Cytochrome b-245, beta polypeptide |
| NOX3 | GP91-3 | NM_015718 | NADPH oxidase 3 |
| NOX4 | KOX/KOX-1/RENOX | NM_016931 | NADPH oxidase 4 |
| NOX5 | MGC149776/MGC149777/NOX5A/NOX5B | NM_024505 | NADPH oxidase, EF-hand calcium binding domain 5 |
| RAC1 | MGC111543/MIG5/TC-25/p21-Rac1 | NM_006908 | Ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) |
| RAC2 | EN-7/Gx/HSPC022 | NM_002872 | Ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
| SOD1 | ALS/ALS1/IPOA/SOD/homodimer | NM_000454 | Superoxide dismutase 1, soluble |
| SOD2 | IPO-B/MNSOD/Mn-SOD | NM_000636 | Superoxide dismutase 2, mitochondrial |
| ACTB | PS1TP5BP1 | NM_001101 | Actin, beta |
The official full names, gene symbols, aliases, and accession numbers for the mRNA targets included in the PCR array.
Figure 2Variability of non-target redox enzymes. (A) Changes in off-target expression levels for wild-type Jurkat cells relative to pLKO empty vector control cells. Genes with significantly altered mRNA levels are colored green. (B) Changes in off-target expression levels for Grx1 shRNA (blue, circles), Trx1 shRNA (red, diamonds) and G6PD shRNA (orange, triangles), relative to pLKO control. (C) Venn diagram of significant gene changes. Statistical significance for all plots based upon p < 0.05.
Figure 3Correlation between protein and mRNA levels. Representative blots showing variation in (A) Prx2 and (B) Duox1 protein levels due to off-target effects of lentiviral shRNA. Correlation between protein levels derived from these blots and mRNA level for (C) Prx2 and (D) Duox1 in shRNA cell lines and wild type Jurkat cells.
Figure 4Prediction of co-variance. (A) Loadings plot of principal component analysis indicates strong co-variance between Grx1 and Prx2. (B) Off-target "modulation" of Prx2 by variable silencing of Grx1 in epi-allelic cell lines shows co-variance of Grx1 and Prx2 levels in three of four cell lines.
Cell-line specific parameter sets for computational modeling
| Initial condition/rate constant | Jurkat | pLKO | Grx1 shRNA | Trx1 shRNA | G6PD shRNA |
|---|---|---|---|---|---|
| Grx1-SH (μM) | 1.2 | 1.2 | 1.2 | 1.2 | |
| Trx1ox + Trx1red (μM) | 0.505 | 0.505 | 0.505 | 0.505 | |
| G6PD (M⋅s-1) | 3.75e-4 | 3.75e-4 | 3.75e-4 | ||
| Prx2-SH2 (μM) | 19.2 | 19.2 | |||
| Srx1 (s-1) | 3e-3 | 3e-3 | 3e-3 | ||
| CAT (μM) | 0.9 | 0.9 | 0.9 | ||
Numbers in bold represent altered parameters from the wild-type Jurkat cell line.
Figure 5Simulated consequences of the redox effects of off-target variations in shRNA perturbation. Model predicted dynamics of intracellular H2O2 accumulation (first column), glutathione redox potential (second column), thioredoxin redox potential (third column), and Pr-SSG accumulation (fourth column) after a 100 μM extracellular H2O2 treatment. Solid lines represent the model-predicted behavior for the ideal KD cell lines with no off-target effects (w.t., Grx1, Trx1, G6PD), and dashed lines represent the model-predicted behavior for the experimentally characterized shRNA cell lines with qRT PCR-determined off-target effects (pLKO, Grx1*, Trx1*, G6PD*).
Figure 6G6PD off-target effect significantly alters intracellular redox capacity in knockdown cell lines. Model predicted dynamics of intracellular H2O2 accumulation (first column), glutathione redox potential (second column), thioredoxin redox potential (third column), and Pr-SSG accumulation (fourth column) in the Grx1 knockdown cell line after a 100 μM extracellular H2O2 treatment. Solid black lines represent the model-predicted behavior for the ideal knockdown cell lines with no off-target effects (Grx1), red dashed lines represent the model-predicted behavior for the experimentally characterized shRNA cell lines with all qRT PCR-determined off-target effects except those affecting the G6PD enzyme, and blue dotted lines represent the model-predicted behavior for Grx1 silencing only in the presence of G6PD off-target effects.